BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22565648)

  • 1. Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome.
    Ponti G; Pastorino L; Pollio A; Nasti S; Pellacani G; Mignogna MD; Tomasi A; Del Forno C; Longo C; Bianchi-Scarrà G; Ficarra G; Seidenari S
    Fam Cancer; 2012 Sep; 11(3):411-8. PubMed ID: 22565648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome.
    Pastorino L; Pollio A; Pellacani G; Guarneri C; Ghiorzo P; Longo C; Bruno W; Giusti F; Bassoli S; Bianchi-Scarrà G; Ruini C; Seidenari S; Tomasi A; Ponti G
    PLoS One; 2012; 7(8):e43827. PubMed ID: 22952776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameloblastoma associated with the nevoid basal cell carcinoma (Gorlin) syndrome.
    Eslami B; Lorente C; Kieff D; Caruso PA; Faquin WC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):e10-3. PubMed ID: 18417377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.
    Sun LS; Li XF; Li TJ
    J Dent Res; 2008 Jun; 87(6):575-9. PubMed ID: 18502968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome.
    Ponti G; Pollio A; Mignogna MD; Pellacani G; Pastorino L; Bianchi-Scarrà G; Di Gregorio C; Magnoni C; Azzoni P; Greco M; Seidenari S
    Cancer Genet; 2012 Apr; 205(4):177-81. PubMed ID: 22559979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PTCH2 gene alterations in keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome].
    Xu LL; Li TJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 40(1):15-8. PubMed ID: 18278130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTCH germline mutations in Chinese nevoid basal cell carcinoma syndrome patients.
    Li TJ; Yuan JW; Gu XM; Sun LS; Zhao HS
    Oral Dis; 2008 Mar; 14(2):174-9. PubMed ID: 18302678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple nevoid basal cell carcinoma syndrome associated with congenital orbital teratoma, caused by a PTCH1 frameshift mutation.
    Rodrigues AL; Carvalho A; Cabral R; Carneiro V; Gilardi P; Duarte CP; Puente-Prieto J; Santos P; Mota-Vieira L
    Genet Mol Res; 2014 Jul; 13(3):5654-63. PubMed ID: 25117323
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ponti G; Manfredini M; Pastorino L; Maccaferri M; Tomasi A; Pellacani G
    Anticancer Res; 2018 Jan; 38(1):471-476. PubMed ID: 29277811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on keratocystic odontogenic tumors].
    Li TJ; Sun LS; Luo HY; Yuan JW; Gao L; Gu XM; Li XF; Xu LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Feb; 41(1):16-20. PubMed ID: 19221557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review.
    Guo YY; Zhang JY; Li XF; Luo HY; Chen F; Li TJ
    PLoS One; 2013; 8(10):e77305. PubMed ID: 24204797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations of the PTCH gene in families with odontogenic keratocysts and nevoid basal cell carcinoma syndrome.
    Song YL; Zhang WF; Peng B; Wang CN; Wang Q; Bian Z
    Tumour Biol; 2006; 27(4):175-80. PubMed ID: 16675912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTCH1 mutations in odontogenic keratocysts: are they related to epithelial cell proliferation?
    Pan S; Li TJ
    Oral Oncol; 2009 Oct; 45(10):861-5. PubMed ID: 19362041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis.
    Pan S; Dong Q; Sun LS; Li TJ
    Clin Cancer Res; 2010 Jan; 16(2):442-50. PubMed ID: 20068110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic screening for nevoid basal cell carcinoma syndrome in patients with a solitary keratocystic odontogenic tumour is not useful.
    Karagozoglu KH; Van Hagen JM; Baart JA; Van Der Waal I
    Minerva Stomatol; 2011; 60(1-2):1-4. PubMed ID: 21252844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts.
    Vered M; Peleg O; Taicher S; Buchner A
    J Oral Pathol Med; 2009 Aug; 38(7):597-604. PubMed ID: 19473442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of Sonic Hedgehog signaling pathway proteins (Shh, Ptch1, Ptch2, Smo, Gli1, Gli2, and Gli3) in sporadic and syndromic odontogenic keratocysts.
    Hoyos Cadavid AM; Kaminagakura E; Rodrigues MFSD; Pinto CAL; Teshima THN; Alves FA
    Clin Oral Investig; 2019 Jan; 23(1):153-159. PubMed ID: 29564556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTCH mutations in sporadic and Gorlin-syndrome-related odontogenic keratocysts.
    Gu XM; Zhao HS; Sun LS; Li TJ
    J Dent Res; 2006 Sep; 85(9):859-63. PubMed ID: 16931872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nevoid basal cell carcinoma syndrome with corpus callosum agenesis, PTCH1 mutation and absence of basal cell carcinoma].
    Mazzuoccolo LD; Martínez MF; Muchnik C; Azurmendi PJ; Stengel F
    Medicina (B Aires); 2014; 74(4):307-10. PubMed ID: 25188659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of BRAFV600E mutation in odontogenic keratocysts.
    França JA; de Sousa SF; Diniz MG; Pereira TDSF; de Resende TAC; Santos JND; Gomez RS; Gomes CC
    J Oral Pathol Med; 2018 Feb; 47(2):186-191. PubMed ID: 29272070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.